From the Division of Nephrology, Dialysis, and Renal Transplantation, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico, Milano, Italy.
Exp Clin Transplant. 2020 Jun;18(3):385-389. doi: 10.6002/ect.2018.0107. Epub 2018 Dec 31.
West Nile virus infection is more frequently associated with neuroinvasive disease and high morbidity and mortality in immunocompromised hosts. Here, we describe a 47-year-old Egyptian kidney transplant recipient who was admitted to our department in 2016 for persistent fever, altered mental status, and upper limb tremors. In addition, renal impairment, signs of acute thrombotic microangiopathy, pancreatitis, and slightly altered inflammatory indices were present. The patient was treated with antibacterial and antiviral therapy, and reduced immunosuppressive therapy was prescribed. After several biochemical and instrumental examinations, only slight blood positivity for West Nile virus immunoglobulin M in the absence of immunoglobulin G was found, whereas immunoglobulins M and G on cerebrospinal fluid and West Nile virus polymerase chain reaction were negative. Serology evaluated after 23 days of hospitalization confirmed immunoglobulin M positivity and detected weak immunoglobulin G positivity; however, according to the US Centers for Disease Control and Prevention diagnostic criteria, it was not sufficient to confirm diagnosis. During hospitalization, clinical recovery was observed, but severe renal insufficiency persisted. Renal biopsy performed after clinical recovery demonstrated chronic antibody-mediated rejection with advanced chronic lesions, without viral cytopathic signs. Four months later, we received confirmation of West Nile virus infection by plaque reduction neutralization test. The current case described severe West Nile virus infection with clinical neurologic involvement, thrombotic microangiopathy, and pancreatitis, resulting in irreversible loss of kidney function. Delayed diagnosis, based on US Centers for Disease Control and Prevention criteria, was due to absence of both characteristic radiologic features and sensitive and promptly available laboratory tests. This case stresses the need for accurate diagnostic tests and/or a partial revision of the diagnostic criteria. In fact, with an earlier diagnosis, we would have avoided diagnostic and therapeutic procedures that may have contributed to the loss of graft function in the described case.
西尼罗河病毒感染在免疫功能低下宿主中更常导致神经侵袭性疾病和高发病率及死亡率。在此,我们描述了 1 例 47 岁埃及肾移植受者,其于 2016 年因持续性发热、精神状态改变和上肢震颤而入住我科。此外,该患者还存在肾功能不全、急性血栓性微血管病、胰腺炎和炎症指标略有改变的表现。患者接受了抗菌和抗病毒治疗,并接受了减少免疫抑制治疗。经过多次生化和仪器检查,仅发现轻微的西尼罗河病毒免疫球蛋白 M 阳性,而免疫球蛋白 G 阴性,而脑脊液中的免疫球蛋白 M 和 G 以及西尼罗河病毒聚合酶链反应均为阴性。住院 23 天后进行的血清学检查证实了免疫球蛋白 M 阳性,并发现免疫球蛋白 G 弱阳性;然而,根据美国疾病控制与预防中心的诊断标准,这不足以确诊。住院期间,临床恢复,但严重的肾功能不全持续存在。临床恢复后进行的肾活检显示存在慢性抗体介导的排斥反应,伴有晚期慢性病变,无病毒细胞病变迹象。4 个月后,我们通过蚀斑减少中和试验证实了西尼罗河病毒感染。本病例描述了严重的西尼罗河病毒感染,伴有临床神经系统受累、血栓性微血管病和胰腺炎,导致肾功能不可逆转的丧失。根据美国疾病控制与预防中心的标准,延迟诊断是由于缺乏特征性的放射学特征以及敏感和及时的实验室检测。本病例强调了需要进行准确的诊断性检查和/或对诊断标准进行部分修订。实际上,如果能更早诊断,我们就可以避免在描述的病例中可能导致移植物功能丧失的诊断和治疗程序。